Sort
11,323 grants matching “glioblastoma”
Characterization of GEFT AS a Novel Glioblastoma Oncogene
$185,690Milan Girish Chheda · Sloan-Kettering Inst Can Research · K08 · FY2014 · NS
TISSUE CORE
$185,667Daniel J Brat · Emory University · P30 · FY2010 · CA
Modeling low-grade gliomas using human pluripotent stem cells
$185,625Rui Zhao · University Of Alabama At Birmingham · R21 · FY2018 · NS
Neurologic Oncology Program
$185,525Susan M Chang · University Of California, San Francisco · P30 · FY2025 · CA
PVSRIPO in melanoma
$185,397Georgia Beasley · Duke University · K08 · FY2024 · CA
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
$185,371Courtney A Miller · Scripps Florida · R61 · FY2022 · NS
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors
$185,295Tracy T Batchelor · Massachusetts General Hospital · K24 · FY2007 · CA
B7H1 Mediated Immunosuppression in Glioma
$185,260Orin Bloch · University Of California At Davis · R01 · FY2018 · CA
Efficacy of Dendritic Cell Vaccines Targeting CMV in Glioblastoma (phase 2 DC vaccine)
$185,105Duane A. Mitchell · University Of Florida · R01 · FY2017 · CA
Targeting MELK-mediated EZH2 signaling in glioma stem cells
$185,033Ichiro Nakano · University Of Alabama At Birmingham · R01 · FY2015 · NS
A new kinase inhibitor for glioblastoma
$184,875Raymond Daniel Blind · Vanderbilt University Medical Center · R21 · FY2020 · CA
Investigating Pathophysiology of Glioma Stem Cells in 3D Bioprinted Vascularized Glioblastoma Model
$184,761Irtisha Singh · Texas A&M University Health Science Ctr · R21 · FY2023 · NS
Imaging
$184,722Christopher T Whitlow · Wake Forest University Health Sciences · P01 · FY2021 · CA
Metabolic reprogramming to improve EGFRvIII CAR T cell persistence
$184,717John H Sampson · Duke University · R21 · FY2021 · CA
Inhibiting glioma dispersal using non-toxic, natural products
$184,618John S Kuo · University Of Wisconsin-Madison · R21 · FY2013 · CA
Characterization of GEFT AS a Novel Glioblastoma Oncogene
$184,610Milan Girish Chheda · Sloan-Kettering Inst Can Research · K08 · FY2013 · NS
Tools for Large-Scale Analysis of Driver Pathways
$184,500Rachel Karchin · Johns Hopkins University · R21 · FY2009 · CA
Mass Spectrometry, Proteomics and Metabolomics Core
$184,479John M Asara · Brigham And Women'S Hospital · P01 · FY2016 · CA
Targeting invasive plasticity by inhibiting mitochondrial adaptations to matrix metalloproteinase loss
$184,406Laura Catherine Kelley · Duke University · R21 · FY2023 · CA
Novel Platform linking cancer-specific glycosylation with cell signaling outcomes
$184,375Karen L. Abbott · Florida International University · R21 · FY2020 · CA
Preclinical Validation of Polyvalent siRNA Gold Nanoparticle Conjugates as anti-G
$184,314Alexander H. Stegh · Northwestern University At Chicago · U54 · FY2011 · CA
Therapeutic Evaluation of Magnetic Nanoprobes Specific for Malignant Tumor Marker
$184,229Rheal A Towner · Oklahoma Medical Research Foundation · R21 · FY2009 · CA
Novel Cell Delivery Method for Brain Tumor Therapy
$183,969Behnam Badie · Beckman Research Institute/City Of Hope · R21 · FY2014 · CA
Novel c-Met and Tie-2 antagonists against human glioma
$183,826Youzhi Tong · Angion Biomedica Corporation · R43 · FY2007 · CA
Thermally Targeted Delivery of c-Myc Inhibitory Polypeptides to Malignant Gliomas
$183,788Drazen Raucher · University Of Mississippi Med Ctr · R21 · FY2010 · CA